Bindia Jharap

2.7k total citations · 1 hit paper
45 papers, 1.6k citations indexed

About

Bindia Jharap is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Epidemiology. According to data from OpenAlex, Bindia Jharap has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 21 papers in Genetics and 19 papers in Epidemiology. Recurrent topics in Bindia Jharap's work include Inflammatory Bowel Disease (21 papers), Acute Lymphoblastic Leukemia research (21 papers) and Microscopic Colitis (14 papers). Bindia Jharap is often cited by papers focused on Inflammatory Bowel Disease (21 papers), Acute Lymphoblastic Leukemia research (21 papers) and Microscopic Colitis (14 papers). Bindia Jharap collaborates with scholars based in Netherlands, United States and Canada. Bindia Jharap's co-authors include Jean‐Frédéric Colombel, Giulia Roda, Neeraj Narula, Nanne K.H. de Boer, Chris J. Mulder, Adriaan A. van Bodegraven, Ad A. van Bodegraven, Peer de Graaf, Ronald K. Linskens and Margien L. Seinen and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Bindia Jharap

41 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

2016 501 citations Giulia Roda, Bindia Jharap et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bindia Jharap Netherlands	18	976	621	594	413	355	45	1.6k
Jeroen M. Jansen Netherlands	19	1.2k 1.3×	156 0.3×	944 1.6×	442 1.1×	362 1.0×	48	1.5k
Brihad Abhyankar United States	13	1.8k 1.8×	172 0.3×	1.4k 2.4×	585 1.4×	543 1.5×	37	2.1k
Judith Collins United States	9	1.3k 1.3×	116 0.2×	1.0k 1.7×	357 0.9×	354 1.0×	18	1.7k
Jeffrey Axler United States	8	1.9k 1.9×	159 0.3×	1.5k 2.5×	695 1.7×	565 1.6×	16	2.4k
Azhar Ansari United Kingdom	20	661 0.7×	1.1k 1.8×	355 0.6×	117 0.3×	145 0.4×	51	1.7k
Bella Ungar Israel	23	1.8k 1.9×	203 0.3×	1.4k 2.3×	971 2.4×	508 1.4×	89	2.3k
Michael J. Burt New Zealand	18	417 0.4×	229 0.4×	512 0.9×	109 0.3×	419 1.2×	28	1.3k
Satoshi Motoya Japan	21	961 1.0×	98 0.2×	732 1.2×	367 0.9×	330 0.9×	65	1.4k
Benjamin Pariente France	23	1.4k 1.5×	121 0.2×	1.1k 1.8×	420 1.0×	665 1.9×	88	1.8k
Yulia Ron Israel	14	793 0.8×	115 0.2×	600 1.0×	411 1.0×	273 0.8×	47	1.1k

Countries citing papers authored by Bindia Jharap

Since Specialization

Citations

This map shows the geographic impact of Bindia Jharap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bindia Jharap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bindia Jharap more than expected).

Fields of papers citing papers by Bindia Jharap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bindia Jharap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bindia Jharap. The network helps show where Bindia Jharap may publish in the future.

Co-authorship network of co-authors of Bindia Jharap

This figure shows the co-authorship network connecting the top 25 collaborators of Bindia Jharap. A scholar is included among the top collaborators of Bindia Jharap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bindia Jharap. Bindia Jharap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simsek, Melek, Marjon A. de Boer, Dirk P. van Asseldonk, et al.. (2024). Multicentre study and systematic review: Allopurinol exposure during pregnancy. Alimentary Pharmacology & Therapeutics. 60(4). 503–518. 10 indexed citations

Camps, María Teresa, Gerard Dijkstra, Sander van der Marel, et al.. (2024). P190 Identification of clinical risk factors for postoperative endoscopic recurrence in Crohn’s disease: a prospective, multicenter cohort study. Journal of Crohn s and Colitis. 18(Supplement_1). i498–i498.

Mahmmod, Nofel, et al.. (2021). P414 Obesity is associated with a higher risk of immunogenicity to adalimumab, but not to infliximab in patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 15(Supplement_1). S420–S422. 2 indexed citations

Baas, Dominique, et al.. (2020). Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container. Digestive Diseases and Sciences. 66(5). 1477–1487. 7 indexed citations

Asseldonk, Dirk P. van, Melek Simsek, Nanne K.H. de Boer, et al.. (2019). Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients. Scandinavian Journal of Gastroenterology. 54(6). 753–760. 9 indexed citations

Jharap, Bindia, et al.. (2019). Thiopurines with low-dose allopurinol (ThiLDA)—a prospective clinical one-way crossover trial. European Journal of Clinical Pharmacology. 75(12). 1669–1674. 6 indexed citations

Colombel, J F, Bindia Jharap, William J. Sandborn, et al.. (2016). Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. Alimentary Pharmacology & Therapeutics. 45(1). 50–62. 33 indexed citations

Hu, Jianzhong, Justin Côté-Daigneault, Hina Panchal, et al.. (2016). P735. Exploring mechanisms of inflammatory bowel disease transmission in utero through the microbiome: the MECONIUM Study Pilot. Journal of Crohn s and Colitis. 10(suppl 1). S482–S483. 1 indexed citations

Asseldonk, Dirk P. van, Bindia Jharap, Joanne Verheij, et al.. (2016). The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease. Inflammatory Bowel Diseases. 22(9). 2112–2120. 39 indexed citations

10.

Lorente, Rufo, Cristina Verdejo, Óscar Roncero, et al.. (2015). P403. Colectomy is not a cure for ulcerative colitis: A systematic review. Journal of Crohn s and Colitis. 9(suppl 1). S280–S281.

11.

Jharap, Bindia, Dirk P. van Asseldonk, Nanne K.H. de Boer, et al.. (2015). Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement. PLoS ONE. 10(6). e0120299–e0120299. 40 indexed citations

12.

Narula, Neeraj, Bindia Jharap, & Jean–Frédéric Colombel. (2015). Management of Severe Ulcerative Colitis. Current Treatment Options in Gastroenterology. 13(1). 59–76. 2 indexed citations

13.

Jharap, Bindia, Nanne K.H. de Boer, Pieter Stokkers, et al.. (2013). Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut. 63(3). 451–457. 102 indexed citations

14.

Meij, Tim G. J. de, et al.. (2013). Long‐term follow‐up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 38(1). 38–43. 62 indexed citations

15.

Asseldonk, Dirk P. van, Elisabeth Bloemena, G. den Hartog, et al.. (2010). Liver Histology of Ibd Patients Who Are Treated with 6-Thioguanine Due to Failure of Conventional Thiopurines Reveals Very Few Cases of Nodular Regenerative Hyperplasia. Pure Amsterdam UMC. 100(7). 464–464. 4 indexed citations

16.

Graaf, Peer de, Nanne K.H. de Boer, Susanne Karner, et al.. (2010). Influence of 5‐aminosalicylic acid on 6‐thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy. British Journal of Pharmacology. 160(5). 1083–1091. 50 indexed citations

17.

Asseldonk, Dirk P. van, Bindia Jharap, Dirk J. Kuik, et al.. (2010). Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis. Digestive and Liver Disease. 43(2). 110–115. 29 indexed citations

18.

Graaf, Peer de, René Vos, Nanne K.H. de Boer, et al.. (2010). Limited stability of thiopurine metabolites in blood samples: Relevant in research and clinical practise. Journal of Chromatography B. 878(19). 1437–1442. 25 indexed citations

19.

Jharap, Bindia, Margien L. Seinen, Nanne K.H. de Boer, et al.. (2010). Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts. Inflammatory Bowel Diseases. 16(9). 1541–1549. 167 indexed citations

20.

Boer, Nanne K.H. de, Dennis R. Wong, Bindia Jharap, et al.. (2007). Dose-Dependent Influence of 5-Aminosalicylates on Thiopurine Metabolism. The American Journal of Gastroenterology. 102(12). 2747–2753. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact